On 18 November the annual European Antibiotic Awareness Day takes place. The aim of this European public health initiative is to raise awareness about the threat of antibiotic resistance to public health and the importance of prudent antibiotic use. The number of patients infected by resistant bacteria is increasing across the European Union, causing a major threat to public health. To reduce the development of resistant bacteria prudent use of antibiotics is very important and this will help to keep effective antibiotics available for future generations.
AIMMS researchers of the STAR and STAR PLUS programme work in the field of antibiotic resistance and development. The AIMMS researchers are trying to increase the understanding of resistance development and to find new antibiotic targets. Underneath you can find a list of ongoing antibiotic research projects.
Understanding resistance evolution and persister formation
Design of peptide-derived antibiotics that block interactions between bacterial cell division proteins
New antibiotic target in Gram-negative bacteria: blocking the transport of virulence factors
Cytochrome P450 enzymes of Mycobacterium tuberculosis: novel therapeutic target for an old enemy
Development of new molecular strategies by identifying and characterizing switching factors in Mycobacterium tuberculosis
Bacterial energy metabolism as potential anti-tuberculosis target
Tracking exosomal communication during microbial infection